drugset / Trial / NCT00822029

Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy

NCT00822029

Phase 3 Terminated 2 enrolled Department of Clinical Research and Innovation
RandomizedParallel-groupDouble-blindTreatment

Summary

It is a double blind randomized study aiming at estimating the efficiency of oral bisphosphonates on the decrease of osteoporosis by comparing the evolution of densitometric values between two groups of children (treatment versus placebo).

Timeline

Start
2009-02
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule 70 mg Oral